Inna V. Dolzhikova
Moscow, MOW 123098, Russian Federation
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 44 publications
Adenoviral Vectors Expressing Optimized preM/E Genes of WNV Deliver Long-Term Protection Against Lethal West Nile Virus Challenge.
Journal: Vaccines
Published: October 27, 2025
An Ex Vivo Lung Histoculture Model for Studying Pulmonary Infection and Immune Response With SARS-CoV-2 as an Example of RNA Virus.
Journal: Bio-protocol
Published: September 09, 2025
Immunization route-mediated differences in long-term maturation of humoral immune response induced by adenovirus vector-based COVID-19 vaccine Sputnik V in nonhuman primates.
Journal: Frontiers in immunology
Published: May 23, 2025
Ultra-potent RBM-specific single-domain antibody broadly neutralizes multiple SARS-CoV-2 variants with picomolar activity.
Journal: International journal of biological macromolecules
Published: February 18, 2025
Real-Time PCR-Based Test as a Research Tool for the Retrospective Detection and Identification of SARS-CoV-2 Variants of Concern in a Sample.
Journal: International journal of molecular sciences
Published: January 22, 2025
The Parameters of Long-Term Humoral Immunity Induced by a Single Injection of the Sputnik Light Vaccine Among Noninfected Volunteers and Those Infected with SARS-CoV-2.
Journal: Acta naturae
Published: September 16, 2024
Structural Basis for Evasion of New SARS-CoV-2 Variants from the Potent Virus-Neutralizing Nanobody Targeting the S-Protein Receptor-Binding Domain.
Journal: Biochemistry. Biokhimiia
Published: September 01, 2024
Safety and immunogenicity of GamEvac-Combi, a heterologous rVSV- and rAd5-vectored Ebola vaccine: a randomized controlled multicenter clinical trial in the Republic of Guinea and Russia.
Journal: Frontiers in immunology
Published: August 27, 2024
Immunogenicity and Protectivity of Sputnik V Vaccine in hACE2-Transgenic Mice against Homologous and Heterologous SARS-CoV-2 Lineages Including Far-Distanced Omicron BA.5.
Journal: Vaccines
Published: August 21, 2024
Cytokine production in an ex vivo model of SARS-CoV-2 lung infection.
Journal: Frontiers in immunology
Published: June 13, 2024
New conjugates based on N4-hydroxycytidine with more potent antiviral efficacy in vitro than EIDD-2801 against SARS-CoV-2 and other human coronaviruses.
Journal: Antiviral research
Published: January 31, 2024
In Vitro Antiviral Activity of a New Indol-3-carboxylic Acid Derivative Against SARS-CoV-2.
Journal: Acta naturae
Published: October 03, 2023
Last Updated: 09/26/2026